Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
06 09 2023
Historique:
received: 23 05 2023
revised: 17 08 2023
accepted: 30 08 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

The SARS-CoV-2 entry into host cells is mainly mediated by the interactions between the viral spike protein (S) and the ACE-2 cell receptor, which are highly glycosylated. Therefore, carbohydrate binding agents may represent potential candidates to abrogate virus infection. Here, we evaluated the in vitro anti-SARS-CoV-2 activity of two mannose-binding lectins isolated from the Brazilian plants

Identifiants

pubmed: 37766292
pii: v15091886
doi: 10.3390/v15091886
pmc: PMC10536204
pii:
doi:

Substances chimiques

Antiviral Agents 0
Mannose-Binding Lectins 0
Lectins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Biochem Cell Biol. 2013 Apr;45(4):807-15
pubmed: 23353644
Front Cell Infect Microbiol. 2020 Nov 25;10:587269
pubmed: 33324574
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Nat Chem Biol. 2022 Sep;18(9):963-971
pubmed: 35676539
Biomed Pharmacother. 2022 Feb;146:112507
pubmed: 34891122
Front Cardiovasc Med. 2021 Jan 15;7:618651
pubmed: 33521067
Int J Biol Macromol. 2019 Aug 1;134:901-911
pubmed: 31108148
Appl Microbiol Biotechnol. 2011 Jan;89(1):45-55
pubmed: 20890754
Biochem Biophys Res Commun. 2011 May 20;408(4):566-70
pubmed: 21530490
Expert Rev Gastroenterol Hepatol. 2015 May;9(5):547-58
pubmed: 25846301
Antimicrob Agents Chemother. 2014;58(1):120-7
pubmed: 24145548
Int J Mol Sci. 2021 Sep 22;22(19):
pubmed: 34638545
J Virol. 2010 Mar;84(5):2511-21
pubmed: 20032190
Front Mol Biosci. 2021 Apr 13;8:629873
pubmed: 33928117
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
Cell Insight. 2022 Jun 29;1(4):100046
pubmed: 37192863
Braz J Med Biol Res. 2005 Dec;38(12):1769-73
pubmed: 16302091
Talanta. 2000 Oct 2;53(1):233-46
pubmed: 18968108
Pharmacol Res. 2021 Oct;172:105820
pubmed: 34403732
Biopolymers. 2002;67(6):470-86
pubmed: 12209454
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Front Immunol. 2022 Apr 04;13:855496
pubmed: 35444647
J Tradit Complement Med. 2011 Oct;1(1):41-50
pubmed: 24716104
Food Chem Toxicol. 2019 Dec;134:110827
pubmed: 31542433
Front Microbiol. 2020 Dec 15;11:608924
pubmed: 33384677
Sci Rep. 2021 Apr 22;11(1):8717
pubmed: 33888774
Sci Rep. 2023 May 9;13(1):7547
pubmed: 37161022
Sci Rep. 2018 May 23;8(1):8059
pubmed: 29795295
Cureus. 2022 Jul 1;14(7):e26486
pubmed: 35919213
Curr Protoc Microbiol. 2008 Nov;Appendix 4:Appendix 4E
pubmed: 19016439
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
Biomol Ther (Seoul). 2014 Jan;22(1):41-6
pubmed: 24596620
J Virol. 2013 Jun;87(11):6257-69
pubmed: 23536670
J Feline Med Surg. 2018 Apr;20(4):378-392
pubmed: 28901812
Antiviral Res. 2007 Sep;75(3):179-87
pubmed: 17428553
Acta Trop. 2022 Mar;227:106300
pubmed: 34979144
J Biol Chem. 2017 Aug 11;292(32):13402-13414
pubmed: 28652405
PLoS One. 2013 May 21;8(5):e64449
pubmed: 23700478
J Biomol Struct Dyn. 2021 Aug;39(12):4510-4521
pubmed: 32568012
Food Sci Nutr. 2021 Mar 25;9(6):2908-2914
pubmed: 34136158
Front Pharmacol. 2017 Oct 04;8:671
pubmed: 29046636
Br J Cancer. 2006 May 22;94(10):1460-4
pubmed: 16622450
Int J Biol Macromol. 2020 Mar 1;146:841-852
pubmed: 31726163
Mol Biochem Parasitol. 2018 Oct;225:67-72
pubmed: 30217772
Antiviral Res. 2021 Aug;192:105122
pubmed: 34186107
Saudi J Biol Sci. 2022 Jun;29(6):103301
pubmed: 35475119
MethodsX. 2018 May 30;5:599-608
pubmed: 29984193
Antiviral Res. 2020 Dec;184:104955
pubmed: 33091434
Int J Mol Sci. 2018 Mar 31;19(4):
pubmed: 29614752
Virus Res. 2023 Jan 15;324:199029
pubmed: 36565816
Braz Dent J. 2019 Oct 07;30(5):437-445
pubmed: 31596327
Virology. 2020 Sep;548:39-48
pubmed: 32838945
Cell Host Microbe. 2020 Sep 9;28(3):475-485.e5
pubmed: 32735849
Structure. 2006 Jul;14(7):1127-35
pubmed: 16843894
Spectrochim Acta A Mol Biomol Spectrosc. 2019 Feb 5;208:85-96
pubmed: 30292907
J Med Virol. 2022 Jul;94(7):3101-3111
pubmed: 35229317
Biopolymers. 2005 Aug 15;78(6):311-7
pubmed: 15898120
Antiviral Res. 2017 Jun;142:37-54
pubmed: 28322922
Mol Cell Proteomics. 2021;20:100058
pubmed: 33077685
Biospectroscopy. 1998;4(2):75-91
pubmed: 9557903
Front Cell Infect Microbiol. 2016 Nov 25;6:164
pubmed: 27933277
Emerg Microbes Infect. 2021 Dec;10(1):1519-1529
pubmed: 34278967
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Int J Biol Macromol. 2014 Apr;65:167-75
pubmed: 24456898
J Biomol Struct Dyn. 2022 Jun;40(9):3880-3898
pubmed: 33292056
Infect Genet Evol. 2020 Nov;85:104502
pubmed: 32798769
Signal Transduct Target Ther. 2020 Dec 4;5(1):283
pubmed: 33277466
Antimicrob Agents Chemother. 2011 Nov;55(11):5159-67
pubmed: 21896910
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
Nat Commun. 2021 Nov 5;12(1):6415
pubmed: 34741049
Signal Transduct Target Ther. 2021 Nov 15;6(1):396
pubmed: 34782609
Evid Based Complement Alternat Med. 2013;2013:729081
pubmed: 23935676
Int J Mol Sci. 2020 Jul 08;21(14):
pubmed: 32650484
Cell Rep. 2020 Aug 11;32(6):108016
pubmed: 32755598
Gene. 1995 Aug 19;161(2):151-6
pubmed: 7665070
Exp Cell Res. 2021 Jun 1;403(1):112594
pubmed: 33823179
Clin Microbiol Infect. 2022 Feb;28(2):202-221
pubmed: 34715347
Biomimetics (Basel). 2021 Dec 25;7(1):
pubmed: 35076456
Viruses. 2023 May 16;15(5):
pubmed: 37243261
J Appl Microbiol. 2018 Nov;125(5):1238-1252
pubmed: 30053345
Immunol Lett. 2008 Dec 22;121(2):148-56
pubmed: 19014972
Arch Virol. 2013 Feb;158(2):349-58
pubmed: 23053519
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865
J Am Chem Soc. 2003 Feb 19;125(7):1731-7
pubmed: 12580598
Med. 2022 Apr 8;3(4):262-268.e4
pubmed: 35313451
Front Microbiol. 2020 Aug 13;11:1818
pubmed: 32903349

Auteurs

Victória Riquena Grosche (VR)

Laboratory of Antiviral Research, Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia 38405-317, Brazil.
Institute of Biosciences, Languages, and Exact Sciences (Ibilce), São Paulo State University (Unesp), São José do Rio Preto 15054-000, Brazil.

Leandro Peixoto Ferreira Souza (LPF)

Innovation Center in Salivary Diagnostic and Nanobiotechnology, Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia 38405-317, Brazil.

Giulia Magalhães Ferreira (GM)

Laboratory of Antiviral Research, Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia 38405-317, Brazil.

Marco Guevara-Vega (M)

Innovation Center in Salivary Diagnostic and Nanobiotechnology, Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia 38405-317, Brazil.

Tamara Carvalho (T)

Institute of Biosciences, Languages, and Exact Sciences (Ibilce), São Paulo State University (Unesp), São José do Rio Preto 15054-000, Brazil.

Romério Rodrigues Dos Santos Silva (RRDS)

Center of Agrarian Science and Biodiversity, Federal University of Cariri (UFCA), Crato 63130-025, Brazil.

Karla Lilian Rodrigues Batista (KLR)

Laboratory of Microbial Pathogenesis, CEUMA University, São Luís 65045-380, Brazil.

Rodrigo Paolo Flores Abuna (RPF)

Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Oswaldo Cruz Foundation (Fiocruz), Bi-Institutional Platform for Translational Medicine, Ribeirão Preto 14049-900, Brazil.

João Santana Silva (JS)

Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Oswaldo Cruz Foundation (Fiocruz), Bi-Institutional Platform for Translational Medicine, Ribeirão Preto 14049-900, Brazil.

Marília de Freitas Calmon (MF)

Institute of Biosciences, Languages, and Exact Sciences (Ibilce), São Paulo State University (Unesp), São José do Rio Preto 15054-000, Brazil.

Paula Rahal (P)

Institute of Biosciences, Languages, and Exact Sciences (Ibilce), São Paulo State University (Unesp), São José do Rio Preto 15054-000, Brazil.

Luis Cláudio Nascimento da Silva (LCN)

Laboratory of Microbial Pathogenesis, CEUMA University, São Luís 65045-380, Brazil.

Bruno Silva Andrade (BS)

Laboratory of Bioinformatics and Computational Chemistry, State University of Southwest of Bahia, Jequié 45205-490, Brazil.

Claudener Souza Teixeira (CS)

Center of Agrarian Science and Biodiversity, Federal University of Cariri (UFCA), Crato 63130-025, Brazil.

Robinson Sabino-Silva (R)

Innovation Center in Salivary Diagnostic and Nanobiotechnology, Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia 38405-317, Brazil.

Ana Carolina Gomes Jardim (ACG)

Laboratory of Antiviral Research, Institute of Biomedical Science (ICBIM), Federal University of Uberlândia (UFU), Uberlândia 38405-317, Brazil.
Institute of Biosciences, Languages, and Exact Sciences (Ibilce), São Paulo State University (Unesp), São José do Rio Preto 15054-000, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH